Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SUPERNUS PHARMACEUTICALS, INC. v. ACTAVIS INC. et al
Case Number:
1:13-cv-04740
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 05, 2016
Supernus Gets Partial Win In Drug Patent Row With Actavis
Supernus Pharmaceuticals Inc. won a partial victory Friday in its bid to stop Actavis Inc. from bringing a generic version of the epilepsy drug Oxtellar XR to market when a New Jersey federal judge ruled the planned generic would infringe two Supernus patents.
-
November 18, 2015
NJ Patent Trial Witnesses Recount Drug-Making Challenges
Actavis Inc. copied formulas for a novel anti-seizure drug that took Supernus Pharmaceuticals Inc. years and millions of dollars to develop and market, according to testimony Wednesday as the the companies' patent infringement trial began in New Jersey federal court.
-
November 16, 2015
Actavis Wants Courtroom Sealed In Anti-Seizure Drug Trial
A New Jersey federal judge about to preside over a pharmaceutical patent infringement trial has agreed to entertain defendant Actavis Inc.'s requests to bar trade secrets and other sensitive information about its anti-seizure drug from being aired in a public courtroom.